| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.26B | -3.9% |
| R&D Expense | $2.0M | -96.2% |
| SG&A Expense | $236.7M | -5.2% |
| Operating Income | $1.29B | -13.4% |
| Pre-tax Income | $1.33B | -21.7% |
| Income Tax | $0 | — |
| Net Income | $859.0M | -24.3% |
| EPS (Basic) | $1.92 | -24.4% |
| EPS (Diluted) | $1.91 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $929.0M | +94.8% |
| Current Assets | $1.80B | +41.4% |
| Total Assets | $18.22B | +11.2% |
| Current Liabilities | $1.25B | +676.8% |
| Long-term Debt | $7.61B | +24.1% |
| Total Liabilities | $7.88B | +25.1% |
| Stockholders' Equity | $10.34B | +2.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.77B | -7.3% |
| Investing Cash Flow | -$2.68B | -29.2% |
| Financing Cash Flow | $361.1M | +116.8% |
| -24.5% |